Clinical Trial Update: A Study of HDM2020 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is an update on a Phase 1 study of HDM2020 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• HDM2020

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING